グライカン媒介によるB細胞抑制による胎児の耐性の確立
G Rizzuto1, J F Brooks2, S T Tuomivaara3,4,5
1Department of Pathology, University of California San Francisco, San Francisco, CA, USA.
Nature
|March 3, 2022
まとめ
妊娠中の母親の免疫耐性は,グリカン媒介のB細胞抑制によって達成される. CD22- LYNシグナル伝達とシアライテッドグリカンを含むこのプロセスは,胎盤抗原に対するT細胞の活性化を防ぐ.
科学分野:
- 免疫学
- グライコバイオロジー
- 生殖免疫学
背景:
- 免疫には自己非自己の差別が不可欠です
- 胎盤に対する母親の免疫耐性は,妊娠中に拒絶を防ぐ.
- トロフォブラスト抗原に対するB細胞耐性のメカニズムは,ほとんど不明である.
研究 の 目的:
- 胎児と母親の耐性を確立するB細胞の役割を調査する.
- 妊娠中のB細胞抑制のメカニズムを特定する.
- 免疫耐性に対するグリカン構造の影響を調査する.
主な方法:
- マウスにおけるトロフォブラスト抗原に対するB細胞耐性を研究した.
- CD22- LYN阻害信号伝達経路を調査した.
- 抗原表現とT細胞抑制におけるシアライテッドグリカンの役割を分析した.
- トロフォブラスト由来シオログリコプロテインが 検出された
主要な成果:
- ネズミの胎児への耐性には,グリカン媒介によるB細胞抑制が不可欠である.
- トロフォブラスト抗原に特異的なB細胞は,CD22- LYNシグナル伝達によって抑制されます.
- 抗原のシアライテッドグリカンは,抑制性の決定因子である.
- B細胞はCD4+T細胞に抗原を提示し,T細胞抑制を誘導する.
- トロフォブラストシオログリコプロテインは,マウスとヒトの母体循環に存在します.
結論:
- 胎盤に対する母親の免疫耐性の鍵となるメカニズムである.
- この発見は妊娠の合併症や 腫瘍の免疫回避の理解に 影響を及ぼします
- グライカンの生物学を活用することで,自己免疫疾患における免疫反応を制御するための新しい戦略を提供することができる.
関連する概念動画
01:22Development of Immunocompetence
482
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
482
01:15Transcytosis of IgG
3.0K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.0K
01:20Special Features of Adaptive Immunity
1.2K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
1.2K
01:31Hybridoma Technology
15.5K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.5K
01:40Cell-mediated Immune Responses
74.7K
Overview
74.7K